254 related articles for article (PubMed ID: 20530684)
1. Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.
Bagheri-Yarmand R; Nanos-Webb A; Biernacka A; Bui T; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5085-95. PubMed ID: 20530684
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
Bagheri-Yarmand R; Biernacka A; Hunt KK; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5074-84. PubMed ID: 20530685
[TBL] [Abstract][Full Text] [Related]
3. Distinct pools of cdc25C are phosphorylated on specific TP sites and differentially localized in human mitotic cells.
Franckhauser C; Mamaeva D; Heron-Milhavet L; Fernandez A; Lamb NJ
PLoS One; 2010 Jul; 5(7):e11798. PubMed ID: 20668692
[TBL] [Abstract][Full Text] [Related]
4. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
Akli S; Zheng PJ; Multani AS; Wingate HF; Pathak S; Zhang N; Tucker SL; Chang S; Keyomarsi K
Cancer Res; 2004 May; 64(9):3198-208. PubMed ID: 15126360
[TBL] [Abstract][Full Text] [Related]
6. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
[TBL] [Abstract][Full Text] [Related]
7. The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.
Roshak AK; Capper EA; Imburgia C; Fornwald J; Scott G; Marshall LA
Cell Signal; 2000 Jun; 12(6):405-11. PubMed ID: 11202906
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G
Shen Y; Sherman JW; Chen X; Wang R
J Biol Chem; 2018 Apr; 293(14):5185-5199. PubMed ID: 29467227
[TBL] [Abstract][Full Text] [Related]
9. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function.
Cogswell JP; Brown CE; Bisi JE; Neill SD
Cell Growth Differ; 2000 Dec; 11(12):615-23. PubMed ID: 11149596
[TBL] [Abstract][Full Text] [Related]
10. Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation.
Bahassi el M; Hennigan RF; Myer DL; Stambrook PJ
Oncogene; 2004 Apr; 23(15):2658-63. PubMed ID: 14968113
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin activation of polo-like kinase 1 is required during mitotic entry.
Dai G; Qian Y; Chen J; Meng FL; Pan FY; Shen WG; Zhang SZ; Xue B; Li CJ
Biochem Cell Biol; 2013 Oct; 91(5):287-94. PubMed ID: 24032677
[TBL] [Abstract][Full Text] [Related]
12. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
[TBL] [Abstract][Full Text] [Related]
13. The polo-like kinase 1 regulates CDC25B-dependent mitosis entry.
Lobjois V; Jullien D; Bouché JP; Ducommun B
Biochim Biophys Acta; 2009 Mar; 1793(3):462-8. PubMed ID: 19185590
[TBL] [Abstract][Full Text] [Related]
14. Characterization of centrosomal localization and dynamics of Cdc25C phosphatase in mitosis.
Bonnet J; Coopman P; Morris MC
Cell Cycle; 2008 Jul; 7(13):1991-8. PubMed ID: 18604163
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
Akli S; Keyomarsi K
Cancer Biol Ther; 2003; 2(4 Suppl 1):S38-47. PubMed ID: 14508079
[TBL] [Abstract][Full Text] [Related]
16. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
17. Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.
Duong MT; Akli S; Macalou S; Biernacka A; Debeb BG; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2013 Sep; 73(17):5556-68. PubMed ID: 23955388
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells.
Schmidt M; Hofmann HP; Sanders K; Sczakiel G; Beckers TL; Gekeler V
Mol Cancer Ther; 2006 Apr; 5(4):809-17. PubMed ID: 16648550
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.
Hutchins JR; Dikovskaya D; Clarke PR
Mol Biol Cell; 2003 Oct; 14(10):4003-14. PubMed ID: 14517314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
